Stockscreener 앱 받기
22.69
3.68%
0.805
Sanara Medtech Inc 주식(SMTI)의 최신 뉴스
Sanara MedTech Inc. (SMTI) Tops Q3 Earnings Estimates - MSN
Sanara MedTech Shareholders Reaffirm Board and Governance Policies - TipRanks
Sanara MedTech (SMTI) investors approve board, auditor and 3-year say-on-pay cycle - Stock Titan
Responsive Playbooks and the SMTI Inflection - Stock Traders Daily
[Form 4] Sanara MedTech Inc. Insider Trading Activity - Stock Titan
Sanara MedTech (SMTI) director receives 4,154 restricted shares, total holdings 26,858 - Stock Titan
Sanara MedTech (SMTI) director Ronald Nixon receives 4,154 restricted shares grant - Stock Titan
Sanara MedTech director granted 4,385 restricted shares | SMTI Insider Trading - Stock Titan
Sanara MedTech Ends Catalyst Advisory Deal, Refocuses Strategy - TipRanks
Sanara Medtech Terminates Services Agreement With Catalyst Effective June 2 - TradingView
Sanara MedTech Ends Advisory Services Agreement With The Catalyst Group Amid Strategy Shift - TradingView
Sanara MedTech (NASDAQ: SMTI) terminates Catalyst advisory agreement - Stock Titan
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - AOL.com
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - The Motley Fool
SMTI Stock Price, Quote & Chart | SANARA MEDTECH INC (NASDAQ:SMTI) - ChartMill
Sanara MedTech Inc. (SMTI) Slides as Support Test Looms; Medtech Sector Sentiment WeighsIchimoku Entry - The Legal Advocate
Sanara MedTech (SMTI) Falls 4.2% as Selling Pressure Intensifies Near SupportFloat Adjusted Cap - newsline.com
Sanara MedTech (SMTI) Gains 1.75% as Stock Tests Key Resistance LevelGEX Level - newsline.com
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript - AOL.com
Understanding the Setup: (SMTI) and Scalable Risk - Stock Traders Daily
Sanara MedTech Dips After Swing to Profit - Bez Kabli
Sanara MedTech (SMTI) Edges Lower Amid Modest Trading, Holds Above Key SupportMarket Leader Picks - The Legal Advocate
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Shareholders to Connect - ACCESS Newswire
Sanara MedTech (SMTI) Q1 2026 Earnings: EPS $0.05 Beats EstimatesReturn On Equity - The Legal Advocate
Sanara MedTech (SMTI) Q1 2026 Earnings Beat: Revenue $N/A, EPS $0.05Viral Trade Signals - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - PR Newswire
Pomerantz LLP investigates Sanara MedTech for p... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Sanara MedTech (SMTI) CEO reports share withholding to cover tax on vested stock - Stock Titan
Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Gr - The National Law Review
The Technical Signals Behind (SMTI) That Institutions Follow - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
2026-05-15 | Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Stockholders to Inquire about Securities Investigation | NDAQ:SMTI | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Sanara MedTech: From Cash Burner To Profitable Growth (NASDAQ:SMTI) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Investors to Reach Out - ACCESS Newswire
Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2026 Earnings Call Transcript - Insider Monkey
Sanara MedTech Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Sanara outlines Q2 2026 net revenue of $28.5M-$29.5M while reaffirming $116M-$121M full-year outlook - MSN
Lake Street Maintains Sanara MedTech(SMTI.US) With Buy Rating, Maintains Target Price $32 - 富途牛牛
Sanara MedTech (SMTI) posts Q1 2026 profit as revenue reaches $27.8M - Stock Titan
Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Stro - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Sanara MedTech (SMTI) Reports Strong Q1 Revenue Growth and Impro - GuruFocus
2026-05-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Reach Out | NDAQ:SMTI | Press Release - Stockhouse
Earnings call transcript: Sanara MedTech Q1 2026 beats EPS expectations, stock surges - Investing.com
Earnings call transcript: Sanara MedTech Q1 2026 beats EPS expectations, stock surges By Investing.com - Investing.com South Africa
Transcript: Sanara MedTech Q1 2026 Earnings Conference Call - Benzinga
Sanara MedTech Sees 2Q Rev $28.5M-$29.5M >SMTI - Moomoo
Sanara MedTech Q1 2026 Earnings Call Transcript - MarketBeat
Sanara MedTech's Surgical Pivot Delivers Q1 Profitability - BriefGlance
1.68%
0.71%
자본화:
|
볼륨(24시간):